Skip to main content

Table 2 Euvolemic hemodialysis patient’s antihypertensive medication and comorbidities (n = 145)

From: Hypertension control among euvolemic hypertensive hemodialysis patients in Malaysia: a prospective follow-up study

Patient variables No. (%)
Antihypertensive medication
 ACE-I 12 (8.3)
 ARBs 36 (24.8)
 CCBs 43 (29.7)
 Alpha antagonist 6 (4.1)
 Beta antagonist 42 (29)
 Diuretics 41 (28.3)
Antihypertensive combination therapy 15 (10.3)
Co-morbid conditions
 Hypertension 118 (81.3)
 Diabetes mellitus 97 (66.9)
 Cardiovascular diseases 20 (13.8)
 Cerebrovascular accident 14 (9.7)
 Hyperlipidemia 20 (13.8)
 Gouty arthritis 18 (12.4)
 Other comorbiditiesa 41 (28.3)
  1. ACE-I Angiotensin converting enzyme inhibitors, ARBs Angiotensin receptor blockers, CCBs Calcium channel blockers, aOther comorbidities: Blood clots, depression, asthma, osteoarthritis, pregnancy losses/birth defects and osteoporosis